New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer

被引:41
作者
Conteduca, Vincenza [1 ]
Mosca, Alessandra [2 ]
Brighi, Nicole [1 ]
de Giorgi, Ugo [1 ]
Rescigno, Pasquale [3 ]
机构
[1] Ist Sci Romagnolo Studio Cura Tumori IRST, Dept Med Oncol, IRCCS, I-47014 Meldola, Italy
[2] FPO IRCCS, Candiolo Canc Inst, Multidisciplinary Outpatient Oncol Clin, I-10060 Turin, Italy
[3] FPO IRCCS, Candiolo Canc Inst, Interdisciplinary Grp Translat Res & Clin Trials, Urol Canc GIRT Uro, I-10060 Turin, Italy
关键词
prostate cancer; androgen receptor; PTEN; DNA repair defects; prognostic biomarkers; ANDROGEN RECEPTOR; DNA-REPAIR; INCREASED SURVIVAL; ENZALUTAMIDE; ABIRATERONE; MUTATIONS; PTEN; MEN; EXPRESSION; LETHAL;
D O I
10.3390/cells10010193
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Prostate cancer is one of the most frequent cancers in men and is a common cause of cancer-related death. Despite significant progress in the diagnosis and treatment of this tumor, patients who relapse after radical treatments inevitably develop metastatic disease. Patient stratification is therefore key in this type of cancer, and there is an urgent need for prognostic biomarkers that can define patients' risk of cancer-related death. In the last 10 years, multiple prognostic factors have been identified and studied. Here, we review the literature available and discuss the most common aberrant genomic pathways in metastatic castration-resistant prostate cancer shown to have a prognostic relevance in this setting.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 94 条
[61]   Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancer [J].
Nilbert, M ;
Planck, M ;
Fernebro, E ;
Borg, Å ;
Johnson, A .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (06) :942-945
[62]   Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells [J].
Onstenk, Wendy ;
Sieuwerts, Anieta M. ;
Kraan, Jaco ;
Van, Mai ;
Nieuweboer, Annemieke J. M. ;
Mathijssen, Ron H. J. ;
Hamberg, Paul ;
Meulenbeld, Hielke J. ;
De Laere, Bram ;
Dirix, Luc Y. ;
van Soest, Robert J. ;
Lolkema, Martijn P. ;
Martens, John W. M. ;
van Weerden, Wytske M. ;
Jenster, Guido W. ;
Foekens, John A. ;
de Wit, Ronald ;
Sleijfer, Stefan .
EUROPEAN UROLOGY, 2015, 68 (06) :939-945
[63]   Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer [J].
Pritchard, C. C. ;
Mateo, J. ;
Walsh, M. F. ;
De Sarkar, N. ;
Abida, W. ;
Beltran, H. ;
Garofalo, A. ;
Gulati, R. ;
Carreira, S. ;
Eeles, R. ;
Elemento, O. ;
Rubin, M. A. ;
Robinson, D. ;
Lonigro, R. ;
Hussain, M. ;
Chinnaiyan, A. ;
Vinson, J. ;
Filipenko, J. ;
Garraway, L. ;
Taplin, M. -E. ;
AlDubayan, S. ;
Han, G. C. ;
Beightol, M. ;
Morrissey, C. ;
Nghiem, B. ;
Cheng, H. H. ;
Montgomery, B. ;
Walsh, T. ;
Casadei, S. ;
Berger, M. ;
Zhang, L. ;
Zehir, A. ;
Vijai, J. ;
Scher, H. I. ;
Sawyers, C. ;
Schultz, N. ;
Kantoff, P. W. ;
Solit, D. ;
Robson, M. ;
Van Allen, E. M. ;
Offit, K. ;
de Bono, J. ;
Nelson, P. S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (05) :443-453
[64]   Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer [J].
Pritchard, Colin C. ;
Morrissey, Colm ;
Kumar, Akash ;
Zhang, Xiaotun ;
Smith, Christina ;
Coleman, Ilsa ;
Salipante, Stephen J. ;
Milbank, Jennifer ;
Yu, Ming ;
Grady, William M. ;
Tait, Jonathan F. ;
Corey, Eva ;
Vessella, Robert L. ;
Walsh, Tom ;
Shendure, Jay ;
Nelson, Peter S. .
NATURE COMMUNICATIONS, 2014, 5
[65]   Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide [J].
Rathkopf, D. E. ;
Smith, M. R. ;
Ryan, C. J. ;
Berry, W. R. ;
Shore, N. D. ;
Liu, G. ;
Higano, C. S. ;
Alumkal, J. J. ;
Hauke, R. ;
Tutrone, R. F. ;
Saleh, M. ;
Maneval, E. Chow ;
Thomas, S. ;
Ricci, D. S. ;
Yu, M. K. ;
de Boer, C. J. ;
Trinh, A. ;
Kheoh, T. ;
Bandekar, R. ;
Scher, H. I. ;
Antonarakis, E. S. .
ANNALS OF ONCOLOGY, 2017, 28 (09) :2264-2271
[66]   Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer [J].
Reid, A. H. M. ;
Attard, G. ;
Ambroisine, L. ;
Fisher, G. ;
Kovacs, G. ;
Brewer, D. ;
Clark, J. ;
Flohr, P. ;
Edwards, S. ;
Berney, D. M. ;
Foster, C. S. ;
Fletcher, A. ;
Gerald, W. L. ;
Moller, H. ;
Reuter, V. E. ;
Scardino, P. T. ;
Cuzick, J. ;
de Bono, J. S. ;
Cooper, C. S. .
BRITISH JOURNAL OF CANCER, 2010, 102 (04) :678-684
[67]   Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer [J].
Reid, Alison H. M. ;
Attard, Gerhardt ;
Brewer, Daniel ;
Miranda, Susana ;
Riisnaes, Ruth ;
Clark, Jeremy ;
Hylands, Lucy ;
Merson, Sue ;
Vergis, Roy ;
Jameson, Charles ;
Hoyer, Soren ;
Sorenson, Karina Dalsgaard ;
Borre, Michael ;
Jones, Chris ;
de Bono, Johann S. ;
Cooper, Colin S. .
MODERN PATHOLOGY, 2012, 25 (06) :902-910
[68]  
Rescigno P, 2018, ANN ONCOL, V29
[69]   Characterizing CDK12-Mutated Prostate Cancers [J].
Rescigno, Pasquale ;
Gurel, Bora ;
Pereira, Rita ;
Crespo, Mateus ;
Rekowski, Jan ;
Rediti, Mattia ;
Barrero, Maialen ;
Mateo, Joaquin ;
Bianchini, Diletta ;
Messina, Carlo ;
de la Maza, Maria D. Fenor ;
Chandran, Khobe ;
Carmichael, Juliet ;
Guo, Christina ;
Paschalis, Alec ;
Sharp, Adam ;
Seed, George ;
Figueiredo, Ines ;
Lambros, Maryou ;
Miranda, Susana ;
Ferreira, Ana ;
Bertan, Claudia ;
Riisnaes, Ruth ;
Porta, Nuria ;
Yuan, Wei ;
Carreira, Suzanne ;
de Bono, Johann S. .
CLINICAL CANCER RESEARCH, 2021, 27 (02) :566-574
[70]   Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers [J].
Rescigno, Pasquale ;
Lorente, David ;
Dolling, David ;
Ferraldeschi, Roberta ;
Rodrigues, Daniel Nava ;
Riisnaes, Ruth ;
Miranda, Susana ;
Bianchini, Diletta ;
Zafeiriou, Zafeiris ;
Sideris, Spyridon ;
Ferreira, Ana ;
Figueiredo, Ines ;
Sumanasuriya, Semini ;
Mateo, Joaquin ;
Perez-Lopez, Raquel ;
Sharp, Adam ;
Tunariu, Nina ;
de Bono, Johann S. .
EUROPEAN UROLOGY ONCOLOGY, 2018, 1 (01) :71-77